Strategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read MoreUncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read MoreReducing the Unexpected and Unnecessary Costs of Musculoskeletal Condition Care
Musculoskeletal (MSK) injuries or disorders affect nearly half of U.S. adults1 and are one of the top health categories of plan sponsor spend at $420B. This topic was the focus of a breakout sessi...
Read MoreWhat Is Drug Trend and How to Manage it
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access. This topic was the foc...
Read MoreAntibiotic Resistance: A Threat to All Of Us
When germs no longer respond to antibiotics, the cost to our health and budgets is enormous
Read MoreWith the right formulary, plans can control drug costs while preserving access
Each plan determines which formulary is best for its unique circumstances.
Read MoreTipping the scales to effectively treat obesity
The promise and challenges of semaglutide, a new therapy for weight loss
Read MoreFour Considerations for Designing a Fertility Benefit
The right fertility benefit provides the right treatment to meet each individual member’s needs while delivering value to the plan.
Read MoreThe Need for Comprehensive Fertility Benefits: A Patient Perspective
More and more individuals are turning to fertility treatment as a way to start a family. Employers who offer comprehensive fertility benefits provide peace of mind in helping employees reach their per...
Read More